Welcome, visitor! [ Register | Login rss Google+ facebook twitter LinkedIn Pinterest FeedBurner

← Return to Japanese Biotech Company Announces 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin for Colon Cancer

These novel and significant efficacies have been achieved by the unique nature of the injectable CMG (curcumin monoglucuronide) which can release 10,000 times higher amounts of the curcumin free form in the bloodstream than normal curcumin powder intake orally (patent applied).

By | | Full size is 1464 × 952 pixels

These novel and significant efficacies have been achieved by the unique nature of the injectable CMG (curcumin monoglucuronide) which can release 10,000 times higher amounts of the curcumin free form in the bloodstream than normal curcumin powder intake orally (patent applied).